|
ABOUT COMPANY
Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers. The company is headquartered in Miami, Florida.
|
EARNINGS
Gross Profit (TTM): 47927200
Market Capitalization: 471375000
Operating Margin (TTM): -0.0888
PE Ratio: 65.44
PEG Ratio: 0
Profit Margin: 0.121
Revenue Per Share (TTM): 0.803
Revenue (TTM): 61260000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.332
Trailing PE: 65.44
|
DIVIDENDS
Diluted EPS (TTM): 0.09
Dividend Date: 2014-05-07
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: 1104700
ExDividend Date: 2014-04-28
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|